Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia

NCT01097304 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

NIH

Sponsor class

Conditions

Barrett Esophagus
Esophageal Carcinoma

Interventions

DRUG: Ursodiol
OTHER: Laboratory Biomarker Analysis

Sponsor

National Cancer Institute (NCI)